Rhythm Pharmaceuticals, Inc. - RYTM

SEC FilingsOur RYTM Tweets

About Gravity Analytica

Recent News

  • 06.09.2025 - Goldman Sachs Annual Healthcare Conference
  • 06.04.2025 - Jefferies Global Healthcare Conference
  • 06.04.2025 - Jefferies Global Healthcare Conference
  • 05.14.2025 - Bank of America Securities 2025 Healthcare Conference
  • 05.14.2025 - Bank of America Securities 2025 Healthcare Conference
  • 05.14.2025 - Rhythm Pharmaceuticals Announces New Data Presentations on Patients with Acquired or Congenital Hypothalamic Obesity (N=35) Treated with Setmelanotide for up to Nine Months in French Early-access Program
  • 05.14.2025 - Rhythm Pharmaceuticals Announces New Data Presentations on Patients with Acquired or Congenital Hypothalamic Obesity (N=35) Treated with Setmelanotide for up to Nine Months in French Early-access Program
  • 05.07.2025 - Rhythm Pharmaceuticals 1Q 2025 Earnings Conference Call
  • 05.07.2025 - Rhythm Pharmaceuticals 1Q 2025 Earnings Conference Call
  • 05.07.2025 - Rhythm Pharmaceuticals 1Q 2025 Earnings Conference Call

Recent Filings

  • 05.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.07.2025 - EX-99.1 EX-99.1
  • 05.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 05.07.2025 - 8-K Current report
  • 05.01.2025 - 4 Statement of changes in beneficial ownership of securities
  • 05.01.2025 - 4 Statement of changes in beneficial ownership of securities